Fanatics Collectibles and Kayou Join Forces to Bring NBA Trading Cards to China
3.10.2025 04:00:00 CEST | Business Wire | Press Release
Fanatics Collectibles, via Topps, and Kayou have announced today a partnership to provide NBA trading cards to China through NBA Match Attax 2025. The deal represents a landmark product offering accessible NBA trading cards for basketball fans in China and further growing the country’s passion for the sport. As part of the deal, Kayou, a leading trading card manufacturer in China, will handle the manufacturing and distribution of the product, leveraging its expansive existing distribution network, while Topps will utilize its world class design to delight Chinese fans and collectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251002665209/en/
The deal underscores Fanatics Collectibles’ commitment to growing the Chinese market, as well as its international growth strategy in identifying key markets with passionate sports fans and providing them best-in-class products. Earlier this year, Fanatics Collectibles established offices in both Shanghai and Beijing to further strengthen its local presence. For Kayou, this represents a monumental opportunity to expand its already massive consumer base and work with Fanatics Collectibles to provide China its first NBA/NBPA licensed Topps trading card product.
“We are incredibly excited to partner with Kayou in this historic deal to bring officially licensed trading cards to basketball fans in China,” said Ann Wang, Fanatics Collectibles’ Regional President, APAC. “China is home to one of the largest and most passionate basketball communities in the world, and this partnership reflects Fanatics Collectibles’ commitment to serving fandom by creating products and experiences that bring Chinese fans even closer to the players and sport they love.”
A representative from Kayou, remarked: “We are thrilled to partner with Fanatics Collectibles to deliver the best product experience for NBA fans in China. This collaboration allows Kayou to enter a new realm of sports IP and immerse ourselves in the unique charm of sports culture. Through our joint efforts, we believe we can offer an amazing product at the start of the new NBA season, providing NBA fans and trading card collectors a fresh way to interact with their favorite players and teams.”
NBA Match Attax is the first mass market product released by Fanatics Collectibles and Topps under the new basketball license. To celebrate the license and provide unforgettable experiences to fans and collectors in China, Fanatics Collectibles will be at the Asia Sports Card Show (October 10–12) and NBA House (October 8–12). These events will celebrate the joy of collecting and get fans excited about the world of collectibles and everything Topps has to offer.
NBA Match Attax is available in China online, as well as Kayou flagship stores, hobby shops, and other retailers beginning Oct. 3 with two different SKUs – Power Pack and Super Pack – selling for 10 RMB and 20 RMB per pack, respectively.
About Fanatics Collectibles
Fanatics Collectibles is a new model and vision for the hobby fundamentally changing the experience for current and future collectors, leagues, and players across many professional and college sports. The organization secured long-term, exclusive rights to design, manufacture and distribute trading cards for several sports and entertainment properties, including NBA, MLB, MLBPA, the Premier League, MLS, UFC, Formula 1 as well as Disney, Marvel, Pixar and Star Wars, among others. In January 2022, Fanatics Collectibles announced the acquisition of Topps, establishing the preeminent licensed trading card brand as the cornerstone of Fanatics’ trading cards and collectibles business and jumpstarted its MLB and MLBPA rights to design, manufacture and distribute trading cards.
About Kayou
Kayou is a leading pan-entertainment product company, ranked 66th among the Global Unicorn Index 2025 published by Hurun Wealth, and trusted by a portfolio of 70+ licensed IPs across anime, entertainment, and pop culture. Kayou unites scale, speed, and creative innovation to deliver next-level collectible experiences fans have never seen. Bringing trading cards and collectibles together under one roof, Kayou introduces a whole new dimension of excitement, creating deeper connections for fandoms worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251002665209/en/
Contacts
Ryan Stolz, rstolz@collectfanatics.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom